Skip to search formSkip to main contentSkip to account menu

CDR1 protein, human

Known as: CDR1, Cerebellar Degeneration-Related Protein 1, CDR1 Protein 
Cerebellar degeneration-related antigen 1 (262 aa, ~31 kDa) is encoded by the human CDR1 gene. This protein is involved in autoimmune diseases.
National Institutes of Health

Related topics

Related topics

10 relations

Broader (2)

AutoantigensNerve Tissue Proteins
Autoimmune DiseasesAutoimmune reactionBrainCDR1 gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Cerebellar Degeneration-related Antigen 1 Is Ubiquitously Expressed in Human Epidermis and Dermis
Cerebellar degeneration-related antigen 1 (CDR1) was described to be expressed in the nervous system and in different types of… 
2013
2013
Rationally Designed Transmembrane Peptide Mimics of the Multidrug Transporter Protein Cdr1 Act as Antagonists to Selectively Block Drug Efflux and Chemosensitize Azole-resistant Clinical Isolates of…
Background: Transmembrane peptide mimics (TMPMs) may be useful to prevent helix-helix interaction of multidrug transporter… 
2011
2011
Ncb2 Is Involved in Activated Transcription of CDR1 in Azole-Resistant Clinical Isolates of Candida albicans
ABSTRACT We recently demonstrated that CDR1 overexpression in azole-resistant isolates of Candida albicans is due to its enhanced… 
2008
2008
Effect of commonly used herbicides on the virulence factor CDR1 in Candida albicans
The ubiquitous yeast Candida albicans becomes a troublesome pathogen by inducing virulence factors in response to environmental… 
2007
2007
A T cell receptor associated with naturally occurring human tumor immunity
The onconeural antigens appear to serve as tumor rejection antigens in the paraneoplastic neurologic disorders. Here, we used an… 
2006
2006
Antagonism of Chk1 Signaling in the G2 DNA Damage Checkpoint by Dominant Alleles of Cdr1
Activation of the Chk1 protein kinase by DNA damage enforces a checkpoint that maintains Cdc2 in its inactive, tyrosine-15 (Y15… 
2006
2006
Capisterones A and B, which enhance fluconazole activity in Saccharomyces cerevisiae, from the marine green alga Penicillus capitatus.
A whole-cell-based assay using Saccharomyces cerevisiae strains that overexpress Candida albicans CDR1 and MDR1 efflux pumps has… 
2004
2004
Adriamycin alters the expression of drug efflux pumps and confers amphotericin B tolerance in Candida albicans.
The aim of the work presented here was to establish whether exposure of the yeast C. albicans to adriamycin altered the… 
2004
2004
A case of acquired generalized lipodystrophy with cerebellar degeneration and type 2 diabetes mellitus.
Acquired generalized lipodystrophy (AGL) is a rare disorder of adipose tissue characterized by loss of fat from large regions of… 
2002
2002
Complementary Combining Site Contact Residue Mutations of the Anti-digoxin Fab 26–10 Permit High Affinity Wild-type Binding*
Antibody 26–10, obtained in a secondary immune response, binds digoxin with high affinity (K a = 1.3 × 1010 m −1) because of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)